Female Health Company targets India with grant:
This article was originally published in Clinica
Executive Summary
The Female Health Company has won a £2 million ($2.9 million) grant from the UK government for manufacturing and marketing the female condom in India in a collaboration with Hindustan Latex. The Chicago-based company claims the product is the only device controleed by women that helps to prevent sexually-transmitted diseases, including HIV/AIDS. India has the second highest number of people living with HIV/AIDS, estimated at nearly four million, the company says.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.